South Korea MFDS Proposes WHO Reliance for IVD Approvals
From Medical Device Global Market Access · 05:05
Show by Pure Global
South Korea's Ministry of Food and Drug Safety (MFDS) has proposed a significant amendment, MFDS Notification 2026-508, to its In-Vitro Diagnostic (IVD) approval process. Announced on October 28, 2026, the proposal would allow manufacturers to use clinical performance data from the World Health Organization's (WHO) Prequalification program to satisfy local requirements. This episode details this new reliance pathway, its impact on IVD manufacturers seeking faster market access, and the critical public comment deadline of November 16, 2026. We explore the practical steps regulatory teams should take to prepare for this change and leverage it for a more efficient entry into the South Korean market. Key Questions: - What is South Korea's MFDS proposing for IVD approvals under Notification 2026-508? - How can the WHO Prequalification program accelerate market access in South Korea? - What specific data will be accepted through this new reliance pathway? - What is the deadline for submitting public comments on this proposal? - Which IVD manufacturers will benefit the most from this regulatory change? - How does this proposal align South Korea with global regulatory harmonization efforts? - What are the immediate actions regulatory teams should consider in response? - What happens if a manufacturer does not have WHO Prequalification? - What are the potential cost and time savings for IVD registrations? Sources: - https://www.meridiantrace.com/en/medical-device-regulatory-change-tracker How Pure Global can help: Pure Global offers end-to-end regulatory consulting to help MedTech and IVD companies achieve faster global market access. Our experts develop efficient regulatory strategies, manage technical dossier submissions, and act as your local representative in over 30 countries, including South Korea. We leverage advanced AI to streamline document compilation and track regulatory changes, ensuring your products remain compliant. Whether you are a startup or a multinational enterprise, Pure Global can help you navigate complex pathways like the new MFDS proposal for IVDs. Visit us at https://pureglobal.com, contact us at [email protected], or explore our free AI tools and device database at https://pureglobal.ai.
More episodes of Medical Device Global Market Access
More episodes
- FDA IVD Emerging Pathogens Guidance: Validation for Section 564 Emergencies
- EU Harmonised Standards Update (November 2026): What MDR & IVDR Manufacturers Must Do Now
- China NMPA Medical Device GMP: Compliance for the November 1, 2026 Changes
- Mexico COFEPRIS Extends Medical Device Registration Renewals to 10 Years
- EU MDCG 2026-4 Rev. 1: Manufacturers Now Responsible for EUDAMED SSCP Uploads
- EU EUDAMED Device Registration Deadline: November 2026 Requirements for MDR and IVDR
- UK MHRA Annual Fee Deadline: Urgent Action Required by November 6, 2026
- China NMPA GMP 2026: Navigating Post-Implementation Compliance and Inspections
- Australia TGA CDSS Exemption Changes: New 2026 Rules for SaMD
- India Medical Device Import Rules 2026: Proposed Expansion of Gateways
PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.